Glunz & Jensen A/S
To Nasdaq OMX Copenhagen A/S
Public announcement no. 489
March 10th, 2021
RELATED PARTY TRANSACTION
Glunz & Jensen Holding A/S announces that the company today has received pursuant to section 38 of the Capital Market Act and section 55 of the Danish Companies Act, where Flemming Nyenstad Enevoldsen notifies Glunz & Jensen Holding A/S ("Glunz & Jensen ") that Flemming Nyenstad Enevoldsen has increased his shareholding in Glunz & Jensen by purchasing 863 shares in Glunz & Jensen at nominal DKK 20.
After the purchase, Flemming Nyenstad Enevoldsen owns a total of 4.170 shares, corresponding to 0,23% of the total share capital and voting rights in Glunz & Jensen.
See attached information for further details.
For further information please contact:
CEO Martin Overgaard Hansen: phone +45 22 60 84 05
Chairman of the board Flemming Nyenstad Enevoldsen: phone +45 40 43 13 03
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
VoltaGrid LLC20.10.2025 23:15:00 CEST | Press release
VoltaGrid and Halliburton Announce Strategic Collaboration to Deliver Distributed Power Solutions for the Global Data Center Industry
Teva Pharmaceutical Industries Ltd20.10.2025 22:30:00 CEST | Press release
Teva and Prestige Biopharma Enter License Agreement for Tuznue® Commercialization in Europe
Vicor Corporation20.10.2025 21:50:00 CEST | Press release
Vicor steps up its IP licensing practice
Biotalys NV20.10.2025 18:00:00 CEST | Press release
Regulated information
Syensqo SA20.10.2025 17:45:00 CEST | Press release
Syensqo - Acquisition of own shares
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom